| pubmed-article:17481705 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C1512288 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:17481705 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17481705 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17481705 | pubmed:dateCreated | 2007-6-18 | lld:pubmed |
| pubmed-article:17481705 | pubmed:abstractText | The aim of this study was to explore the co-expression and prognostic relevance of thrombospondin-1 (THBS-1), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and VEGF receptor 1 (VEGFR-1) in epithelial ovarian cancer (EOC). | lld:pubmed |
| pubmed-article:17481705 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17481705 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17481705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17481705 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17481705 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17481705 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:BerchuckAndre... | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:HavrileskyLau... | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:DarcyKathleen... | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:SecordAngeles... | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:HutsonAlanA | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:Gynecologic... | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:LeePaula SPS | lld:pubmed |
| pubmed-article:17481705 | pubmed:author | pubmed-author:GraceLisa ALA | lld:pubmed |
| pubmed-article:17481705 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17481705 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:17481705 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17481705 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17481705 | pubmed:pagination | 221-32 | lld:pubmed |
| pubmed-article:17481705 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:meshHeading | pubmed-meshheading:17481705... | lld:pubmed |
| pubmed-article:17481705 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17481705 | pubmed:articleTitle | Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study. | lld:pubmed |
| pubmed-article:17481705 | pubmed:affiliation | DUMC 3079, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA. secor002@mc.duke.edu <secor002@mc.duke.edu> | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:17481705 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17481705 | lld:pubmed |
